drugset / Trial / NCT00501254

Pharmacodynamic Trial, of Slow Release ASA, in Platelet Functionalism, a Long Term Treatment Period

NCT00501254

Phase 2/3 Completed 100 enrolled Rottapharm Spain
RandomizedParallel-groupDouble-blindPrevention

Summary

Evaluation of the pharmacodynamic profile (antiaggregant profile, balance of prostanoids and nitric oxid) of a ASA-SR (slow-release)formulation in comparison with a ASA NR (normal release), 150 mg, during 12 months of treatment.

Timeline

Start
2005-02
Primary completion
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule